13th International Conference on Biomedical and Cancer Research (Part II)
  • Follow

Accepted Abstracts

The CRISPR Genome Editing Process is an Effective Advancement of Short-Term Cancer Treatment

Ali Adel Dawood* 
University of Mosul, Iraq

Citation: Dawood AA (2021) The CRISPR Genome Editing Process is an Effective Advancement of Short-Term Cancer Treatment. SciTech Biomed-Cancer Sciences 2021. 

Received: December 02, 2020         Accepted: December 09, 2020         Published: December 10, 2020

Abstract

The CRISPR method is considered the biggest biotechnology breakthrough of the century because of its accuracy, effectiveness, and versatility, and it has opened up new possibilities for micro-genome editing and in vivo imaging. Overall, the technology of CRISPR / Cas9 has demonstrated unparalleled therapeutic promise to study and target diseases and to include innovative methods for drug development. To kill cancer cells, scientists are creating a groundbreaking CRISPER based genome editing treatment. A big step in the road to finding a cure for cancer is this recent growth. With other variants of CRISPR, scientists can change genes in more complex ways, such as inserting a new DNA segment or modifying single DNA letters.
 
Keywords: CRISPER, Cancer, Cas9, mRNA, Glioblastoma